LJI308
LJI308 is a potent pan-RSK inhibitor, with IC50 of 6 nM, 4 nM, and 13 nM for RSK1, RSK2, and RSK3, respectively.
| Trivial name | / |
| Catalog Number | CSN17965 |
| Alternative Name(s) | / |
| Research Area | Cancer |
| Molecular Formula | C21H18F2N2O2 |
| CAS# | 1627709-94-7 |
| Purity | ≥98% |
| SMILES | OC1=C(F)C=C(C2=C(C3=CC=C(N4CCOCC4)C=C3)C=CN=C2)C=C1F |
| Size | 25mg |
| Supplier Page | https://www.csnpharm.com/products/lji308.html |